Wells Fargo Reaffirms Their Buy Rating on DR Horton (DHI)

In a report released yesterday, Sam Reid from Wells Fargo maintained a Buy rating on DR Horton, with a price target of $190.00. The company’s shares closed yesterday at $152.59.

Elevate Your Investing Strategy:

• Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

According to TipRanks, Reid is a 4-star analyst with an average return of 6.7% and a 56.69% success rate. Reid covers the Consumer Cyclical sector, focusing on stocks such as DR Horton, Mohawk, and Toll Brothers.

In addition to Wells Fargo, DR Horton also received a Buy from TR | OpenAI – 4o’s Lana Roomette in a report issued on October 8. However, on October 10, Bank of America Securities reiterated a Hold rating on DR Horton (NYSE: DHI).

DHI market cap is currently $45.19B and has a P/E ratio of 12.15.

Based on the recent corporate insider activity of 67 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of DHI in relation to earlier this year. Last month, Michael Buchanan, a Director at DHI sold 1,000.00 shares for a total of $180,740.00.